Samantha R. Morelli

Healthcare & Life Sciences

• AbbVie in its $63 billion acquisition of Allergan, obtaining approval of the divestiture by a 3-2 vote of the FTC, allowing the deal to close less than eleven months after signing
• Bristol-Myers Squibb in its $90 billion acquisition of Celgene and its related $13.4 billion divesture of Celgene’s OTEZLA® program to Amgen, obtaining approval of the divestiture by a 3-2 vote of the FTC, allowing the deal to close less than eleven months after signing
• Eli Lilly and Company (NYSE: LLY) in its $1.4 billion acquisition of POINT Biopharma, a radiopharmaceutical company; its $1.925 billion acquisition of Versanis, a cardiometabolic disease specialist; its $2.4 billion acquisition of autoimmune disease specialist Dice Therapeutics; its $610 million acquisition of Akouos; its $1 billion sale of BAQSIMI to Amphastar Pharmaceuticals; as well as other transactions
• Custopharm in its $425 million sale to Hikma Pharmaceuticals, obtaining approval of the divestiture by a 4-0 vote of the FTC, allowing the deal to close less than seven months after signing
• KKR- and Everstone Capital-backed Slayback Pharma, a provider of generic and specialty pharmaceutical products, in its sale to Azurity Pharmaceuticals
• An EQT-led consortium on the CHF 10.2 billion exclusive negotiations to acquire Nestlé Skin Health, a leading global skincare company
• Nautic Partners in its $570 million acquisition of Tabula Rasa HealthCare (NASDAQ: TRHC), a healthcare company advancing personalized, comprehensive care for value-based care organizations
• Nautic Partners-backed CarepathRx Health System Solutions in its sale of BioPlus Specialty Pharmacy, the nation’s largest independent specialty pharmacy, to Elevance Health (NYSE: ELV); in its strategic partnership with and investment by Evernorth Health Services, a subsidiary of The Cigna Group (NYSE: CI)
• Cinven in its acquisition of Bioclinica, Inc., a leading integrated solutions provider of clinical life science and technology expertise, and the subsequent merger of Bioclinica with ERT
• Linden Capital Partners in its sale of Z-Medica, an industry-leading manufacturer of hemostatic products, to Teleflex Incorporated (NYSE: TFX)
• VSP Vision in its acquisition of Professional Eye Care Associates of America, the nation’s largest community of independent eye care professionals
• Beth Israel Lahey Health System in its acquisition of New Hampshire-based Exeter Health Resources, which comprises Exeter Hospital, Core Physicians and Rockingham Visiting Nurses Association & Hospice, obtaining consent approval by the NH Attorney General, allowing the deal to close less than one year after signing
• Gryphon Partners and Water’s Edge Dermatology in its merger with Riverchase Dermatology
• WellCare Health Plans, Inc. (formerly NYSE: WCG) in its $17.3 billion acquisition by Centene Corporation (NYSE: CNC)

Software & Technology

• HARMAN in its acquisition of Roon, a music management, discovery and streaming platform
• NortonLifeLock (NASDAQ: NLOK) on its merger with Avast, a global leader in digital security and privacy, valued at over $8.6 billion
• Avaya Holdings Corp. (NYSE: AVYA) on its strategic partnership with RingCentral, Inc. (NYSE: RNG)
• ADTRAN, Inc. (NASDAQ: ADTN) in its $2 billion merger with ADVA to create a leading provider of end-to-end fiber networking solutions
• Fortive Corporation (NYSE: FTV) in Industrial Scientific’s $570 million acquisition of Intelex Technologies, global provider of SaaS-based Environmental, Health, Safety and Quality (EHSQ) management software
• Vista Equity Partners-backed Mediaocean in its acquisition of 4C Insights, Inc., a global data science and marketing technology company

Other

• Wyndham Hotels & Resorts in its successful defense of a hostile takeover and full slate proxy contest brought by hostile bidder Choice Hotels International (NYSE: CHH)
• Prince International, an American Securities portfolio company that produces specialty chemicals, minerals, and industrial additives, on its $2.1 billion acquisition of Ferro Corporation and its related divestiture to KPS Capital Partners
• Intelsat in its $400 million carve-out acquisition of the commercial aviation Wi-Fi business of Gogo Inc. (NASDAQ: GOGO)
• Greenbriar Equity Group on the combination of Whitcraft Group with Paradigm Precision, creating a scaled and diversified manufacturer of components used in commercial and military aviation engines
• LyondellBasell Industries (NYSE: LYB), a leading multinational chemicals company, in its acquisition of a 50% stake in chemical processing assets in Lake Charles, LA from Sasol Ltd. and associated licensing transactions